Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomized trials, Lancet, vol.361, pp.13-20, 2003. ,
,
Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction, STREAM Investigative Team, vol.368, pp.1379-1387, 2013. ,
Impact of prehospital thrombolysis for acute myocardial infarction on 1-year outcome: results from the French Nationwide USIC, Registry. Circulation, vol.110, pp.1909-1915, 2000. ,
Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction ,
URL : https://hal.archives-ouvertes.fr/hal-00539344
, Eur Heart J, vol.30, pp.1598-1606, 2009.
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour, Lancet, vol.348, pp.771-775, 1996. ,
Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology, Circulation, vol.115, pp.2570-2589, 2007. ,
Age, clinical presentation, and outcome of acute coronary syndromes in the Euroheart acute coronary syndrome survey, Eur Heart J, vol.27, pp.789-795, 2006. ,
Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry), Am J Cardiol, vol.104, pp.1074-1077, 2009. ,
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.39, pp.119-177, 2017. ,
,
Predicting the development of in-hospital cardiogenic shock in patients with ST-segment elevation myocardial infarction treated by primary percutaneous coronary intervention: the ORBI risk score, Eur Heart J, vol.39, pp.2090-2102, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01833100
White HD; ESC Scientific Document Group. Fourth universal definition of myocardial infarction, Eur Heart J, vol.40, pp.237-269, 2019. ,
,
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation, Eur Heart J, vol.33, pp.2569-2619, 2012. ,
An overview of the objectives of and the approaches to propensity score analyses, Eur Heart J, vol.32, pp.1704-1708, 2011. ,
Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries, Eur Heart J, vol.31, pp.943-957, 2010. ,
Danchin N; FAST-MI 2015 investigators. French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction, Arch Cardiovasc Dis, vol.110, pp.366-378, 2015. ,
Primary angioplasty vs. fibrinolysis in very old patients with acute myocardial infarction: TRIANA (TRatamiento del Infarto Agudo de miocardio eN Ancianos) randomized trial and pooled analysis with previous studies, Eur Heart J, vol.32, pp.51-60, 2011. ,
Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial, Circulation, vol.108, pp.2851-2856, 2003. ,
,
Incidence, timing, predictors and impact of acute heart failure complicating ST-segment elevation myocardial infarction in patients treated by primary percutaneous coronary intervention, Int J Cardiol, vol.221, pp.433-442, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01372350
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy, Circulation, vol.114, pp.2019-2025, 2006. ,
, The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction, GUSTO Angiographic Investigators, vol.329, pp.1615-1622, 1993.
Times to treatment in transfer patients undergoing primary percutaneous coronary intervention in the United States: National Registry of Myocardial Infarction (NRMI)-3/4 analysis, Circulation, vol.111, pp.761-767, 2005. ,
Association of time to reperfusion with left ventricular function and heart failure in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: a systematic review, Am Heart J, vol.165, pp.451-467, 2013. ,
Meta-Analysis Comparing Primary Percutaneous Coronary Intervention Versus Pharmacoinvasive Therapy in Transfer Patients with ST-Elevation Myocardial Infarction, Am J Cardiol, vol.122, pp.542-547, 2018. ,
,
Reduced dose tenecteplase and outcomes in elderly ST-segment elevation myocardial infarction patients: Insights from the STrategic Reperfusion Early After Myocardial infarction trial, Am Heart J, vol.169, pp.890-898, 2006. ,
, Body-mass index (kg/m²) 26
, Hypertension, vol.142
, Glycemia on admission, p.2443
, Symptoms onset-to-FMC delay (min) Symptoms onset-to-FMC delay, vol.180, pp.60-200
, Clopidogrel, vol.261
, Statins, vol.232
, Categorical variables are presented as numbers (percentage)
, ACE= Angiotensin Converting enzyme
, ARB= Angiotensin Receptor Blockers